These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25373768)

  • 1. Biomarkers for early diagnosis of pancreatic cancer.
    Jenkinson C; Earl J; Ghaneh P; Halloran C; Carrato A; Greenhalf W; Neoptolemos J; Costello E
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):305-15. PubMed ID: 25373768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
    Moniaux N; Chakraborty S; Yalniz M; Gonzalez J; Shostrom VK; Standop J; Lele SM; Ouellette M; Pour PM; Sasson AR; Brand RE; Hollingsworth MA; Jain M; Batra SK
    Br J Cancer; 2008 May; 98(9):1540-7. PubMed ID: 18392050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Kriz D; Ansari D; Andersson R
    Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease.
    Wang J; Chen J; Chang P; LeBlanc A; Li D; Abbruzzesse JL; Frazier ML; Killary AM; Sen S
    Cancer Prev Res (Phila); 2009 Sep; 2(9):807-13. PubMed ID: 19723895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
    Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
    Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.
    Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2016 Jul; 22(25):5627-41. PubMed ID: 27433079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma.
    Baraniskin A; Nöpel-Dünnebacke S; Ahrens M; Jensen SG; Zöllner H; Maghnouj A; Wos A; Mayerle J; Munding J; Kost D; Reinacher-Schick A; Liffers S; Schroers R; Chromik AM; Meyer HE; Uhl W; Klein-Scory S; Weiss FU; Stephan C; Schwarte-Waldhoff I; Lerch MM; Tannapfel A; Schmiegel W; Andersen CL; Hahn SA
    Int J Cancer; 2013 Jan; 132(2):E48-57. PubMed ID: 22907602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in pancreatic cancer research: moving towards early detection.
    He XY; Yuan YZ
    World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
    Takai E; Yachida S
    World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
    Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC
    Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
    Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
    Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.
    Sefrioui D; Blanchard F; Toure E; Basile P; Beaussire L; Dolfus C; Perdrix A; Paresy M; Antonietti M; Iwanicki-Caron I; Alhameedi R; Lecleire S; Gangloff A; Schwarz L; Clatot F; Tuech JJ; Frébourg T; Jardin F; Sabourin JC; Sarafan-Vasseur N; Michel P; Di Fiore F
    Br J Cancer; 2017 Sep; 117(7):1017-1025. PubMed ID: 28772284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
    Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
    World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma.
    Chang JC; Kundranda M
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study.
    Bracci PM; Zhou M; Young S; Wiemels J
    Cancer; 2012 Nov; 118(21):5384-94. PubMed ID: 22517435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of pancreatic neoplasia: Current status and future promise.
    Majumder S; Chari ST; Ahlquist DA
    World J Gastroenterol; 2015 Oct; 21(40):11387-95. PubMed ID: 26526068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress on molecular markers of pancreatic cancer.
    Grote T; Logsdon CD
    Curr Opin Gastroenterol; 2007 Sep; 23(5):508-14. PubMed ID: 17762556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for pancreatic cancer: why, how, and who?
    Poruk KE; Firpo MA; Adler DG; Mulvihill SJ
    Ann Surg; 2013 Jan; 257(1):17-26. PubMed ID: 22895395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in serologic detection of human pancreatic adenocarcinoma.
    Eskelinen M; Haglund U
    Scand J Gastroenterol; 1999 Sep; 34(9):833-44. PubMed ID: 10522599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.